MarketsandMarkets Conferences Blogs
Almost 7 years removed from the first FDA approved Biosimilar (Zarxio) in 2015, the US market for Biosimilars is projected to be highly beneficial over the next decade, for both pharmaceutical companies as well as patients, with RAND Corporation projecting estimated savings of over $54 Billion during this period. To truly comprehend such forecasts, a […]
Artificial Intelligence has progressively transitioned from a futuristic technology expected to be decades away, to one whose usage & integration into our daily lives is growing by the minute.From quantum computing to medical diagnostics and the more prevalent trend of autonomous vehicles, AI has well and truly arrived & is here to stay. With a […]
Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts. Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group. He holds a PhD in Genetics from Yale with […]
Ning is a bioinformatics scientist at Arcus Biosciences, where he is responsible for drug discovery, target identification, and indication prioritization in multiple immune-oncology drug programs. Notably, Ning pioneered the 3D organoids based drug response prediction technology, which largely facilitated cancer model selection. During his PhD, he studied with Professor Alexander Hoffmann at UCLA, where he […]
Grace Zhao is a co-founder of Avida Biomed, a biotech start-up specializing in genomic technology innovation for molecular diagnostics. At Avida, Grace co-invented Point-n-Seq, a new platform technology to advance liquid biopsy for early detection of cancer and other diseases. Utilizing the ultra-efficient, hybridization-based pre-amplification enrichment of target molecules from nanogram level cell free DNA […]
Dr. Cátia Moutinho is the Associate Director of Garvan-Weizmann Centre for Cellular Genomics, at the Garvan Institute Sydney-Australia. Also, she is the Group Leader of the Single Cell Technology Development Team. Her group focuses on single-cell genomics development. She is a biologist by training, with a PhD in Biomedicine and a master in Clinical Trials […]
2nd Annual MarketsandMarkets Single-Cell Analysis Virtual Conference to be held on 9th – 10th November 2021 will host industry giants like San Diego Nanotechnology Infrastructure, CHDI Foundation, Brigham Young University, AbSci, Stowers Institute for Medical Research, University of Florence, Pfizer, l’Université et CHU de Montpellier and many more. The single-cell analysis market is projected to […]
3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference to be held on 28th – 29th October 2021 will host industry giants like Advanced Cell & Gene Therapy LLC, Cell & Gene Therapy Consulting LLC, panCella, Sigilon Inc, Biotechnology Biopharmaceuticals and many more. The global cell & gene therapy manufacturing services market size is […]
5th Edition MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference (Time Zone – EST) to be held on 19th – 22nd October 2021 will host industry giants like Sarepta Therapeutics, Idorsia Pharmaceuticals, Food and Drug Administration (FDA), AveXis, Rafael Pharmaceuticals, PicnicHealth, Dedalus Group, RTI Health Solutions, Bluebird Bio, Seagen, Takeda, Takeda Pharmaceuticals, […]
July 12th, 2021- Following up the legacy of 5 very successful annuals in UK & Europe geographies, we are proud to to announce the 6th Edition Infection Control, Sterilization & Decontamination Virtual Conference, Middle East, scheduled for 5th-6th October, 2021. This edition will focus on key topics like the utilization of reprocessed equipment to disinfect […]
